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•	 Bi-directional	communication	with	neurons	and	ensembles	of	
neurons.
•	 Providing	appropriate	and	stable	electrical	interfacing.
•	 Minimizing	tissue	damage	and	scarring.
•	 Rendering	the	devices	as	inert	as	possible	from	the	biocompa-
tibility,	biostability	and	biofouling	standpoints.
Following	these	basic	requirements	great	efforts	have	been	made	
to	develop	penetrating	multielectrode	arrays,	with	dimensions	of	
the	same	order	of	magnitude	as	the	cortical	cells	that	can	be	used	to	
excite	neurons	more	selectively	and	with	electrical	currents	much	
smaller	than	those	used	by	surface	electrodes	(Normann	et	al.,	
1999).	The	two	main	dominated	approaches	are	multiple	insulated	
metal	microwires	(Kralik	et	al.,	2001;	Carmena	et	al.,	2005;	Nicolelis,	
2005;	Musallam	et	al.,	2007;	Ganguly	et	al.,	2009;	Nicolelis	and	
Lebedev,	2009)	and	micromachined	penetrating	microelectrode	
arrays	with	various	substrate	materials,	insulating	dielectrics,	and	
substrate	shaping	technologies	than	can	be	flexible	and	based	on	
polymers	(Stieglitz	and	Meyer,	1999;	Rousche	et	al.,	2001;	Wise,	
2005;	Chen	et	al.,	2009;	Kozai	and	Kipke,	2009)	or	more	rigid	such	
as	the	Utah’s	array	(Normann,	2007),	the	Michigan	array	(Seymour	
and	Kipke,	2007)	or	the	new	NeuroProbes	arrays	(Neves,	2007).
Factors	affecting	brain	tissue	reactions	to	the	implanted	neural	
probes	include	the	mechanical	trauma	during	insertion,	foreign	
body	reaction,	implantation	method	and	physical	properties	of	
the	electrodes.	Thus	there	are	acute	and	chronic	inflammatory	
reactions	which	affect	both	the	neural	tissue	and	the	surface	of	
the	microelectrodes	(Hoogerwerf	and	Wise,	1994;	Woodford	et	al.,	
1996;	Heiduschka	and	Thanos,	1998;	Agnew	et	al.,	1999;	Liu	et	al.,	
1999;	Majji	et	al.,	1999;	Turner	et	al.,	1999;	McCreery	et	al.,	2002).	
These	reactions	often	result	in	damage	of	neural	elements	and	
microelectrodes	and	lead	to	the	proliferation	of	a	glial	scar	around	
the	implanted	spikes	which	prevents	neuronal	fibers	to	be	recorded	
or	stimulated	(Fawcet	and	Asher,	1999;	Turner	et	al.,	1999).	As	a	
IntroductIon
The	treatment	of	neurologic	disorders	and	the	restoration	of	lost	
function	by	neuroprosthetic	devices	has	grown	rapidly	in	the	latest	
years.	For	example,	deep	brain	stimulators	have	been	implanted	
successfully	in	patients	for	pain	management	and	for	control	of	
motor	disorders	such	as	Parkinson’s	disease	(Stieglitz	et	al.,	2004;	
Canavero	and	Bonicalzi,	2007);	cochlear	implants	are	being	used	
for	restoring	auditory	function	and	micro-array	type	devices	have	
been	implanted	in	rudimentary	artificial	vision	systems	(Fernandez	
et	al.,	2005;	Merabet	et	al.,	2007;	Normann	et	al.,	2009).	Moreover	
advances	 in	 artificial	 limbs	 and	 brain-machine	 interfaces	 are	
now	providing	hope	of	increased	mobility	and	independence	for	
amputees	and	paralyzed	patients	and	there	is	preliminary	data	
showing	that	by	using	electrophysiological	methods	it	is	possible	
to	extract	information	about	intentional	brain	processes	and	then	
translate	these	signals	into	models	that	are	able	to	control	external	
devices	(Hochberg	et	al.,	2006;	Donoghue	et	al.,	2007;	Truccolo	
et	al.,	2008).	As	more	and	more	patients	have	benefited	from	this	
approach,	the	interest	in	neural	interfaces	has	grown	significantly.	
However	an	important	problem	reported	with	all	available	neural	
electrodes	to	date,	is	long-term	viability	and	stability.
All	neural	probes	need	a	stable	electronic/neural	interface	that	
enables	selective	recording	and/or	activation	of	specific	groups	of	
neurons	without	deterioration	of	the	electrodes	or	surrounding	
neural	tissue.	To	optimally	record	from	or	excite	neurons,	it	is	
important	to	position	the	microelectrodes	very	close	to	the	neurons	
we	are	trying	to	interact	with	(within	a	few	microns).	This	means	
that	the	electrodes	must	be	located	deep	within	the	nervous	system	
and	have	dimensions	that	are	similar	to	the	size	of	the	neurons.	
Other	important	attributes	are:
•	 Special	design	for	insertion	in	any	part	of	cerebral	cortex,	inclu-
ding	sulci	of	highly	folded	cortices	such	as	those	of	humans.
•	 Reaching	neurons	at	the	desired	three-dimensional	location.
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consequence	one	of	the	major	prerequisites	for	the	application	of	
neural	probes	is	that	the	organism	accepts	the	implant	with	minimal	
tissue	response	(see	next	section).
current concepts of bIocompatIbIlIty of neural 
probes
Biocompatibility	is	used	extensively	within	biomaterial	science,	
but	there	still	exists	a	great	deal	of	uncertainty	about	what	it	actu-
ally	means	and	about	the	mechanisms	that	are	subsumed	within	
the	phenomena	that	collectively	constitute	the	biocompatibility	
(Williams,	2008).	Biocompatibility	has	traditionally	been	con-
cerned	with	aspects	of	biological,	chemical	and	physical	properties	
of	the	implant.	This	implies	that	the	probes	do	not	evoke	a	toxic	or	
immunologic	reaction,	do	not	harm	or	destroy	enzymes,	cells	or	tis-
sues,	do	not	compress	adjacent	tissues	inducing	vascular	problems	
and	be	able	to	remain	for	a	long	term	within	the	organism	without	
encapsulation	or	rejection	(Heiduschka	and	Thanos,	1998).
To	those	who	were	developing	and	using	the	first	generation	
of	implantable	devices	(1940–1980)	it	was	becoming	increasingly	
obvious	that	the	best	performance	was	achieved	with	materials	that	
were	the	least	reactive	chemically	(Williams,	2008).	However,	while	
the	surface	composition	of	the	implant	is	an	important	param-
eter,	in	some	cases	physical	properties	(size,	shape,	stiffness)	are	
the	major	determinants	of	biocompatibility	(Edell	et	al.,	1992;	
Heiduschka	and	Thanos,	1998;	Ward	et	al.,	2009).	Furthermore	
although	it	is	widely	accepted	to	define	biocompatibility	as	“the	
ability	of	a	material	to	perform	with	an	appropriate	host	response	
in	a	specific	application”,	nowadays	any	neural	probe	is	comprised	
of	more	than	one	material,	therefore	we	have	to	move	from	a	mate-
rial	base	to	an	specific	application	base	definition.	Consequently	a	
neural	implant	can	be	considered	to	be	biocompatible	if,
•	 It	performs	its	desired	function	without	eliciting	any	undesira-
ble	local	or	systemic	effect	in	the	recipient	of	the	implant	or	in	
the	own	implant	materials.
•	 It	 remains	 for	 a	 long	 term	 within	 the	 organism,	 entirely	
functional	and	with	the	desired	degree	of	incorporation	in	
the	host.
This	concept	is	not	limited	to	minimize	local	lesions,	but	also	
encloses	the	whole	behavior	of	the	implant	in	its	biological	envi-
ronment	(Walter	et	al.,	1999;	Kohler	et	al.,	2001).	Therefore	three	
areas	have	to	be	considered,	the	“biosafety”,	the	“biofunctionality”	and	
the	“biostability”.	Biosafety	means	that	the	implant	does	not	harm	
its	host	in	any	way,	biofunctionality	is	related	with	the	ability	of	
the	device	to	perform	its	intended	function,	and	biostability	means	
that	the	implant	must	not	be	susceptible	to	attack	of	biological	flu-
ids,	proteases,	macrophages	or	any	substances	of	the	metabolism	
(Heiduschka	and	Thanos,	1998).	In	addition	it	should	also	be	taken	
into	account	the	“biotolerability”	or	the	ability	of	the	implant	to	reside	
in	the	body	for	long	periods	of	time	with	only	low	degrees	of	inflam-
matory	reaction.	All	these	considerations	imply	extreme	demands	
on	stability	and	function	of	neural	implants	and	place	unique	con-
straints	on	the	architecture,	materials,	and	surgical	techniques	used	
in	the	implementation	of	intracortical	microelectrodes.
reactIve responses around neural probes
Implantation	of	any	neural	probe	is	always	a	traumatic	procedure.	
Thus,	when	a	neural	probe	is	inserted	into	the	brain,	some	neurons	
and	glial	cells	are	killed	or	injured	during	insertion,	blood	vessels	
are	disrupted,	and	the	blood-brain	barrier	is	damaged	(Figure 1A).	
This	acute	injury	triggers	a	large	network	of	morphological	and	
metabolic	changes	such	as	the	release	of	cytokines	and	neurotoxic	
Figure 1 | Development of glial encapsulation on an intracortical 
microelectrode. (A) Acute neural injury caused by inserting a microelectrode 
into the brain cortex. Astrocytes and microglial cells become activated and 
migrate to the site of injury. (B) Chronic response showing a dense sheath 
around implanted probes, which contains fibroblasts, macrophages and 
astrocytes. (C,D) The reactive astrocytes, immunohistochemically labeled here 
for GFAP , encapsulate the neural probes forming a dense cellular sheath. 
Calibration bar = 50 μm.Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  3
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must	neurons	be	alive,	but	they	must	also	have	normal	dendritic	
and	axonal	trees,	normal	network	connectivity	and	functional	cell	
bodies	(McConnell	et	al.,	2009).
re-engIneerIng the neural Interface
Recent	studies	on	the	effects	of	neural	injury	following	the	inser-
tion	of	microelectrodes	suggest	that	the	neuroglial	reaction	is	a	
graded,	stereotypic	response	that	can	be	controlled	(Polikov	et	al.,	
2005;	Moxon	et	al.,	2007;	Zhong	and	Bellamkonda,	2007;	Grill	et	al.,	
2009).	In	general,	the	neural	response	has	two	parts,	a	short-	and	a	
long-term	response.	If	the	short-term	response	can	be	controlled,	it	
appears	likely	that	the	reactive	gliosis	and	other	long-term	inflam-
matory	processes	around	neural	probes	can	be	prevented.
Multiple	strategies	have	been	devised	to	regulate	glial	scar	for-
mation.	For	example	by	using	controlled	molecular	engineering	
it	may	be	possible	to	reduce	the	tissue	reaction	around	neural	
probes	as	well	as	to	maximize	the	beneficial	aspects	of	the	response	
and	to	minimize	adverse	responses.	One	approach	to	modulate	
the	inflammatory	response	and	achieve	better	integration	of	the	
neural	probes	with	brain	tissue	is	to	develop	new	coatings	that	
modify	the	neural	probe	surfaces.	A	first	kind	of	surface	modifi-
cations	that	can	be	done	is	the	preparation	of	smooth	or	rough	
surfaces,	but	the	most	widely	used	method	to	enhance	biocompat-
ibility	is	the	chemical	modification	of	neural	probe	surfaces	with	
anti-inflammatory	compounds,	adhesion	proteins,	or	bioactive	
molecules	(Heiduschka	and	Thanos,	1998;	He	et	al.,	2006;	Ludwig	
et	al.,	2006;	Moxon	et	al.,	2007;	Rennaker	et	al.,	2007;	Seymour	and	
Kipke,	2007;	Zhong	and	Bellamkonda,	2007;	Leung	et	al.,	2008;	
Williams,	2008;	Grill	et	al.,	2009).	The	portfolio	of	possible	chemi-
cal	modifications	also	include,	depending	of	the	kind	of	molecules	
bound	to	the	surface,	biological	modifications	such	as	coating	with	
hyaluronic	acid,	peptides,	sugars	or	growth	factors	(Heiduschka	
and	Thanos,	1998;	Dodla	and	Bellamkonda,	2006;	Azemi	et	al.,	
2008;	Dodla	and	Bellamkonda,	2008)	and	non-biological	modi-
fications	as	hydrogels	(Crompton	et	al.,	2007;	Frampton	et	al.,	
2007;	Kim	et	al.,	2010),	polymers	(Ludwig	et	al.,	2006;	Stice	et	al.,	
2007;	Asplund	et	al.,	2009;	Richardson	et	al.,	2009)	and	carbon	
nanotubes	(Lovat	et	al.,	2005;	Mazzatenta	et	al.,	2007;	Pancrazio,	
2008;	Gabriel	et	al.,	2009).
Aside	from	coating	the	electrodes	with	different	biomolecules,	
another	method	to	control	the	glial	response	is	to	fabricate	neural	
probes	with	different	physical	dimensions	and	geometries	(Stice	
et	al.,	2007;	Ward	et	al.,	2009).	However,	although	some	studies	
suggest	that	neural	probe	geometry	is	an	important	parameter	for	
reducing	chronic	tissue	encapsulation	(Seymour	and	Kipke,	2007)	
others	found	that	device	insertion	promotes	two	responses:	an	early	
response	that	is	proportional	to	device	size	and	a	sustained	response	
that	is	independent	of	device	size,	geometry,	and	surface	rough-
ness	and	is	more	likely	due	to	tissue-device	interactions	(Szarowski	
et	al.,	2003).
The	quality	of	the	surgical	procedure	also	plays	a	decisive	role	
for	successfully	long-term	applications	and	deficiencies	in	surgi-
cal	procedures	may	likely	contribute	to	most	of	the	difficulties	in	
chronic	experiments.	Thus	careful	implantation	prevents	cortical	
compression	and	also	seems	to	increase	the	longevity	and	stability	
of	intracortical	microelectrodes	(Nicolelis	et	al.,	1999;	Rennaker	
et	al.,	2005).
free	radicals,	invasion	of	blood-borne	macrophages	and	edema.	
The	damaged	tissue	assumes	a	state	of	emergency,	rapidly	changing	
its	gene	expression	and	stimulating	nearby	microglia	and	astro-
cytes	(Lee	et	al.,	2005;	Polikov	et	al.,	2005;	Biran	et	al.,	2007;	Grill	
et	al.,	2009;	McConnell	et	al.,	2009).	This	mechanically	induced	
wound	healing	response	appears	to	be	of	transitory	nature	since	
electrode	tracks	could	not	be	found	in	animals	after	several	months	
when	the	electrodes	are	inserted	and	quickly	removed	(Polikov	
et	al.,	2005).
We	should	be	aware	that	this	acute	response	plays	an	impor-
tant	role	in	two	crucial	physiological	processes:	protection	against	
infectious	agents	and	repair	of	the	damaged	tissue.	Thus	the	initial	
activation	and	migration	of	microglial	cells	are	likely	beneficial	and	
include	production	of	neurotrophic	substances	and	cell	adhesion	
molecules,	which	support	injured	neurons	and	appear	necessary	
for	restorative	events	to	take	place	(Eddleston	and	Mucke,	1993).	
However,	this	largely	beneficial	initial	phase	usually	results	in	a	
more	adverse	long-term	response	that	is	dependent	of	the	exten-
sion	of	the	injury.	Therefore	these	reactions	often	result	in	damage	
of	neurons	and	microelectrodes	and	lead	to	the	proliferation	of	
a	glial	scar	around	the	implanted	probes	(Figure 1)	which	pre-
vents	neurons	to	be	recorded	or	stimulated	(Polikov	et	al.,	2005;	
Seymour	and	Kipke,	2007;	McConnell	et	al.,	2009).	In	this	way	the	
outer	surface	of	the	neural	probes	is	frequently	surrounded	by	a	
dense	sheath,	which	contains	markers	of	macrophages,	astrocytes	
and	fibroblasts	(Kim	et	al.,	2004).	Furthermore	in	addition	to	the	
astroglial	encapsulation,	there	is	a	persistent	inflammatory	response	
at	the	microelectrode-brain	tissue	interface,	with	abundant	acti-
vated	macrophages	and	a	loss	of	neurons	and	their	projections	
in	the	brain	tissue	immediately	surrounding	the	microelectrodes	
(Figure 2),	that	either	die	or	migrate	away	from	the	interface	(Biran	
et	al.,	2005).	This	long-term	response	is	of	concern	because	increases	
tissue	impedance,	difficult	the	regrowth	of	neuronal	processes	and	
diminishes	the	ability	to	record	and	stimulate	in	long-term	appli-
cations.	In	this	context	it	is	important	to	emphasize	that	not	only	
Figure 2 | Photomicrograph showing astrocytes (gFAP staining, red) 
and neurons (NeuN staining, green) around one microelectrode track 
(asterisk) following chronic implantation of a NeuroProbes 
multielectrode array in rabbit occipital cortex. Calibration bar = 50 μm.Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  4
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tissue	damage	induced	by	these	intracortical	microelectrodes	and	
allow	us	to	achieve	the	therapeutic	benefits	envisioned	by	these	
neural	interfaces.
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challenges and future perspectIves
Understanding	the	interaction	between	the	implanted	device	and	the	
local	cellular	environment	is	critical	for	improving	the	integration	and	
function	of	any	neural	interface.	This	response	needs	to	be	controlled	
to	ensure	the	function	of	the	implant	and	the	desired	degree	of	incor-
poration	in	the	host,	without	eliciting	any	undesirable	local	or	systemic	
effect.	Consequently	some	of	the	main	scientific	challenges	are:
(1)	 Characterization	of	new	coating	technologies	and	biocompa-
tible	coating	materials	(e.g.	peptides	similar	to	extracellular	
matrix	and	hybrid	polymers	with	adjustable	electrical	pro-
perties)	for	improving	the	biocompatibility	and	electroche-
mical	properties	of	neural	interfaces.
(2)	 Improve	 long-term	 biocompatibility	 and	 re-engineer	 the	
brain’s	response	to	the	insertion	of	microelectrodes	through	
controlled	 molecular	 engineering	 to	 find	 a	 balance	 that	
minimizes	any	possible	adverse	response	and	enhances	the	
trophic	responses.
For	future	developments,	it	would	be	desirable	to	promote	
neuronal	growth	toward	electrodes	and	find	special	coverings	for	
the	different	parts	of	the	neuroprosthetic	devices	(recording	elec-
trodes,	stimulating	electrodes,	insulation	material).	These	coatings	
(Figure 3)	will	be	able	to	induce	adhesion,	repulsion,	activation	or	
deactivation	of	specific	cell	types	upon	contact	with	the	modified	
surface	promoting	a	good	incorporation	into	the	tissue	and	help-
ing	to	avoid	undesirable	responses	of	the	immune	system	and	the	
damage	of	the	microelectrodes.
In	the	longer	term,	several	neurological	pathologies	will	be	alle-
viated	by	local	microelectrodes,	but	keeping	these	devices	biologi-
cally	and	electrically	viable	for	many	years	still	remains	a	difficult	
problem.	In	this	context	an	investigation	of	the	submicron	interface	
between	devices	and	nervous	system	cells	is	essential	for	a	better	
understanding	of	the	continued	reaction	of	the	human	body	to	any	
artificial	implant,	no	matter	how	apparently	inert	the	material	is.	We	
expect	that	the	intersection	of	neuroscience	research,	bioengineering,	
and	biomaterials	together	with	intimate	collaborations	among	basic	
scientists,	engineers	and	clinicians	will	help	to	control	the	neural	
Figure 3 | Summary of optimum surface behavior for an implanted 
neural probe. (A) Surface of encapsulation and insulation material: adsorption 
of proteins and adhesion of fibroblast for good incorporation into the tissue, no 
reaction of macrophages. (B) Surface without electrodes: good contact to 
neurons and glial cells, no reaction of macrophages. (C) Surface of electrodes: 
attraction and good contact to neurons, no adhesion of fibroblasts, no 
macrophage reaction.Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  5
Marin and Fernández  Biocompatibility of implantable microelectrodes
Rennaker,	R.	L.,	Miller,	J.,	Tang,	H.,	and	
Wilson,	D.	A.	(2007).	Minocycline	
increases	quality	and	longevity	of	
chronic	neural	recordings.	J. Neural 
Eng. 4,	L1–L5.
Rennaker,	R.	L.,	Street,	S.,	Ruyle,	A.	M.,	
and	Sloan,	A.	M.	(2005).	A	compari-
son	of	chronic	multi-channel	cortical	
implantation	techniques:	manual	ver-
sus	mechanical	insertion.	J. Neurosci. 
Methods 142,	169–176.
Richardson,	R.	T.,	Wise,	A.	K.,	Thompson,	
B.	C.,	Flynn,	B.	O.,	Atkinson,	P.	J.,	
Fretwell,	N.	J.,	Fallon,	J.	B.,	Wallace,	
G.	G.,	Shepherd,	R.	K.,	Clark,	G.	M.,	
and	O’Leary,	S.	J.	(2009).	Polypyrrole-
coated	electrodes	for	the	delivery	of	
charge	and	neurotrophins	to	cochlear	
neurons.	Biomaterials 30,	2614–2624.
Rousche,	P.	J.,	Pellinen,	D.	S.,	Pivin,	D.	P.	Jr.,	
Williams,	J.	C.,	Vetter,	R.	J.,	and	Kipke,	
D.	R.	(2001).	Flexible	polyimide-based	
intracortical	electrode	arrays	with	bio-
active	capability.	IEEE Trans. Biomed. 
Eng. 48,	361–371.
Seymour,	J.	P.,	and	Kipke,	D.	R.	(2007).	
Neural	probe	design	for	reduced	tissue	
encapsulation	in	CNS.	Biomaterials 28,	
3594–3607.
Stice,	P.,	Gilletti,	A.,	Panitch,	A.,	and	
Muthuswamy,	J.	(2007).	Thin	micro-
electrodes	reduce	GFAP	expression	
in	the	implant	site	in	rodent	soma-
tosensory	cortex.	J. Neural Eng. 4,	
42–53.
Stieglitz,	T.,	and	Meyer,	J.	U.	(1999).	
Implantable	microsystems.	Polyimide-
based	neuroprostheses	for	interfac-
ing	nerves. Med. Device Technol. 10,	
28–30.
Stieglitz,	T.,	Schuettler,	M.,	and	Koch,	K.	
P.	(2004).	Neural	prostheses	in	clini-
cal	applications–trends	from	preci-
sion	mechanics	towards	biomedical	
microsystems	in	neurological	reha-
bilitation.	Biomed. Tech. (Berl.) 49,	
72–77.
Szarowski,	D.	H.,	Andersen,	M.	D.,	
Retterer,	S.,	Spence,	A.	J.,	Isaacson,	
M.,	Craighead,	H.	G.,	Turner,	J.	N.,	and	
Shain,	W.	(2003).	Brain	responses	to	
micro-machined	silicon	devices.	Brain 
Res. 983,	23–35.
Truccolo,	W.,	Friehs,	G.	M.,	Donoghue,	
J.	P.,	and	Hochberg,	L.	R.	(2008).	
Primary	 motor	 cortex	 tuning	 to	
intended	movement	kinematics	in	
humans	with	tetraplegia.	J. Neurosci. 
28,	1163–1178.
Turner,	J.	N.,	Shain,	W.,	Szarowski,	D.	H.,	
Andersen,	M.,	Martins,	S.,	Isaacson,	
M.,	and	Craighead,	H.	(1999).	Cerebral	
astrocyte	response	to	micromachined	
silicon	implants.	Exp. Neurol. 156,	
33–49.
Walter,	P.,	Szurman,	P.,	Vobig,	M.,	Berk,	
H.,	Ludtke-Handjery,	H.	C.,	Richter,	
H.,	Mittermayer,	C.,	Heimann,	K.,	
and	Sellhaus,	B.	(1999).	Successful	
McCreery,	D.,	Agnew,	W.	F.,	and	Bullara,	
L.	(2002).	The	effects	of	prolonged	
intracortical	microstimulation	on	
the	excitability	of	pyramidal	tract	
neurons	in	the	cat.	Ann. Biomed. Eng. 
30,	107–119.
Merabet,	L.	B.,	Rizzo,	J.	F.	III,	Pascual-
Leone,	A.,	and	Fernandez,	E.	(2007).	
‘Who	is	the	ideal	candidate?’:	decisions	
and	issues	relating	to	visual	neuro-
prosthesis	development,	patient	test-
ing	and	neuroplasticity.	J. Neural Eng. 
4,	S130–S135.
Moxon,	K.	A.,	Hallman,	S.,	Aslani,	A.,	
Kalkhoran,	N.	M.,	and	Lelkes,	P.	
I.	(2007).	Bioactive	properties	of	
nanostructured	porous	silicon	for	
enhancing	electrode	to	neuron	inter-
faces.	J. Biomater. Sci. Polym. Ed. 18,	
1263–1281.
Musallam,	S.,	Bak,	M.	J.,	Troyk,	P.	R.,	and	
Andersen,	R.	A.	(2007).	A	floating	
metal	microelectrode	array	for	chronic	
implantation.	J. Neurosci. Methods 160,	
122–127.
Neves,	H.	(2007).	Advances	in	cerebral	
probing	using	modular	multifunc-
tional	probe	arrays.	Med. Device 
Technol. 18,	38–39.
Nicolelis,	M.,	Stambaugh,	C.	R.,	Brisben,	
A.,	and	Laubach,	M.	(1999).	“Methods	
for	simultaneous	multisite	neural	
ensemble	recordings	in	behaving	
primates,”	in	Methods for Neural 
Ensemble Recordings,	ed.	M.	Nicolelis	
(Boca	Raton,	FL:	CRC	Press	LLC),	
121–156.
Nicolelis,	M.	A.	(2005).	Computing	with	
thalamocortical	ensembles	during	
different	behavioural	states.	J. Physiol. 
(Lond.) 566,	37–47.
Nicolelis,	M.	A.,	and	Lebedev,	M.	A.	
(2009).	Principles	of	neural	ensemble	
physiology	underlying	the	operation	
of	brain-machine	interfaces.	Nat. Rev. 
Neurosci. 10,	530–540.
Normann,	R.	A.	(2007).	Technology	
insight:	 future	 neuroprosthetic	
therapies	for	disorders	of	the	nerv-
ous	system.	Nat. Clin. Pract. Neurol. 
3,	444–452.
Normann,	R.	A.,	Greger,	B.	A.,	House,	
P.,	Romero,	S.	F.,	Pelayo,	F.,	and	
Fernandez,	E.	(2009).	Toward	the	
development	of	a	cortically	based	
visual	neuroprosthesis.	J. Neural Eng. 
6,	035001.
Normann,	R.	A.,	Maynard,	E.	M.,	Rousche,	
P.	J.,	and	Warren,	D.	J.	(1999).	A	neural	
interface	for	a	cortical	vision	prosthe-
sis.	Vision Res. 39,	2577–2587.
Pancrazio,	J.	J.	(2008).	Neural	interfaces	at	
the	nanoscale.	Nanomedicine (Lond). 
3,	823–830.
Polikov,	V.	S.,	Tresco,	P.	A.,	and	Reichert,	
W.	M.	(2005).	Response	of	brain	tis-
sue	to	chronically	implanted	neural	
electrodes.	J. Neurosci. Methods 148,	
1–18.
of	retinal	degeneration	and	biocom-
patibility	of	subretinal	implants.	
Ophthalmologe 98,	364–368.
Kozai,	T.	D.,	and	Kipke,	D.	R.	(2009).	
Insertion	shuttle	with	carboxyl	termi-
nated	self-assembled	monolayer	coat-
ings	for	implanting	flexible	polymer	
neural	probes	in	the	brain.	J. Neurosci. 
Methods 184,	199–205.
Kralik,	J.	D.,	Dimitrov,	D.	F.,	Krupa,	D.	J.,	
Katz,	D.	B.,	Cohen,	D.,	and	Nicolelis,	
M.	A.	(2001).	Techniques	for	long-
term	multisite	neuronal	ensemble	
recordings	in	behaving	animals.	
Methods 25,	121–150.
Lee,	 H.,	 Bellamkonda,	 R.	 V.,	 Sun,	
W.,	and	Levenston,	M.	E.	(2005).	
Biomechanical	analysis	of	silicon	
microelectrode-induced	strain	in	the	
brain.	J. Neural Eng. 2,	81–89.
Leung,	B.	K.,	Biran,	R.,	Underwood,	
C.	 J.,	 and	 Tresco,	 P.	 A.	 (2008).	
Characterization	of	microglial	attach-
ment	and	cytokine	release	on	bioma-
terials	of	differing	surface	chemistry.	
Biomaterials 29,	3289–3297.
Liu,	X.,	McCreery,	D.	B.,	Carter,	R.	R.,	
Bullara,	L.	A.,	Yuen,	T.	G.,	and	Agnew,	
W.	F.	(1999).	Stability	of	the	interface	
between	neural	tissue	and	chroni-
cally	implanted	intracortical	micro-
electrodes.	IEEE Trans. Rehabil. Eng. 
7,	315–326.
Lovat,	V.,	Pantarotto,	D.,	Lagostena,	L.,	
Cacciari,	B.,	Grandolfo,	M.,	Righi,	M.,	
Spalluto,	G.,	Prato,	M.,	and	Ballerini,	
L.	(2005).	Carbon	nanotube	substrates	
boost	neuronal	electrical	signaling.	
Nano Lett. 5,	1107–1110.
Ludwig,	K.	A.,	Uram,	J.	D.,	Yang,	J.,	Martin,	
D.	C.,	and	Kipke,	D.	R.	(2006).	Chronic	
neural	recordings	using	silicon	micro-
electrode	arrays	electrochemically	
deposited	with	a	poly(3,4-ethylen-
edioxythiophene)	(PEDOT)	film.	J. 
Neural Eng. 3,	59–70.
Majji,	A.	B.,	Humayun,	M.	S.,	Weiland,	
J.	D.,	Suzuki,	S.,	D’Anna,	S.	A.,	and	
de	Juan,	E.	Jr.	(1999).	Long-term	
histological	and	electrophysiologi-
cal	results	of	an	inactive	epiretinal	
electrode	array	implantation	in	
dogs.	Invest. Ophthalmol. Vis. Sci. 40,	
2073–2081.
Mazzatenta,	A.,	Giugliano,	M.,	Campidelli,	
S.,	 Gambazzi,	 L.,	 Businaro,	 L.,	
Markram,	H.,	Prato,	M.,	and	Ballerini,	
L.	(2007).	Interfacing	neurons	with	
carbon	nanotubes:	electrical	signal	
transfer	and	synaptic	stimulation	in	
cultured	brain	circuits.	J. Neurosci. 27,	
6931–6936.
McConnell,	G.	C.,	Rees,	H.	D.,	Levey,	A.	
I.,	Gutekunst,	C.	A.,	Gross,	R.	E.,	and	
Bellamkonda,	R.	V.	(2009).	Implanted	
neural	electrodes	cause	chronic,	local	
inflammation	that	is	correlated	with	
local	neurodegeneration.	J. Neural 
Eng. 6,	56003.
cortex.	IEEE Trans. Biomed. Eng. 39,	
635–643.
Fawcet,	J.	W.,	and	Asher,	R.	A.	(1999).	The	
glial	scar	and	central	nervous	system	
repair.	Brain Res. Bull. 49,	377–391.
Fernandez,	E.,	Pelayo,	F.,	Romero,	S.,	
Bongard,	M.,	Marin,	C.,	Alfaro,	A.,	and	
Merabet,	L.	(2005).	Development	of	a	
cortical	visual	neuroprosthesis	for	the	
blind:	the	relevance	of	neuroplasticity.	
J. Neural Eng. 2,	R1–R12.
Frampton,	J.	P.,	Hynd,	M.	R.,	Williams,	J.	
C.,	Shuler,	M.	L.,	and	Shain,	W.	(2007).	
Three-dimensional	hydrogel	cultures	
for	modeling	changes	in	tissue	imped-
ance	around	microfabricated	neural	
probes.	J. Neural Eng. 4,	399–409.
Gabriel,	G.,	Gomez,	R.,	Bongard,	M.,	
Benito,	N.,	Fernandez,	E.,	and	Villa,	R.	
(2009).	Easily	made	single-walled	car-
bon	nanotube	surface	microelectrodes	
for	neuronal	applications.	Biosens. 
Bioelectron. 24,	1942–1948.
Ganguly,	K.,	Secundo,	L.,	Ranade,	G.,	
Orsborn,	A.,	Chang,	E.	F.,	Dimitrov,	D.	
F.,	Wallis,	J.	D.,	Barbaro,	N.	M.,	Knight,	
R.	T.,	and	Carmena,	J.	M.	(2009).	
Cortical	representation	of	ipsilateral	
arm	movements	in	monkey	and	man.	
J. Neurosci. 29,	12948–12956.
Grill,	 W.	 M.,	 Norman,	 S.	 E.,	 and	
Bellamkonda,	R.	V.	(2009).	Implanted	
neural	interfaces:	biochallenges	and	
engineered	solutions.	Annu. Rev. 
Biomed. Eng. 11,	1–24.
He,	 W.,	 McConnell,	 G.	 C.,	 and	
Bellamkonda,	R.	V.	(2006).	Nanoscale	
laminin	coating	modulates	cortical	
scarring	response	around	implanted	
silicon	microelectrode	arrays.	J. Neural 
Eng. 3,	316–326.
Heiduschka,	P.,	and	Thanos,	S.	(1998).	
Implantable	 bioelectronic	inter-
faces	for	lost	nerve	functions.	Prog. 
Neurobiol. 55,	433–461.
Hochberg,	L.	R.,	Serruya,	M.	D.,	Friehs,	G.	
M.,	Mukand,	J.	A.,	Saleh,	M.,	Caplan,	A.	
H.,	Branner,	A.,	Chen,	D.,	Penn,	R.	D.,	
and	Donoghue,	J.	P.	(2006).	Neuronal	
ensemble	control	of	prosthetic	devices	
by	a	human	with	tetraplegia.	Nature 
442,	164–171.
Hoogerwerf,	A.	C.,	and	Wise,	K.	D.	(1994).	
A	3D	micro-electrode	array	for	chronic	
neural	recording.	IEEE Trans. Biomed. 
Eng. 41,	1136–1146.
Kim,	D.	H.,	Wiler,	J.	A.,	Anderson,	D.	J.,	
Kipke,	D.	R.,	and	Martin,	D.	C.	(2010).	
Conducting	polymers	on	hydrogel-
coated	neural	electrode	provide	sen-
sitive	neural	recordings	in	auditory	
cortex.	Acta Biomater. 6,	57–62.
Kim,	Y.	T.,	Hitchcock,	R.	W.,	Bridge,	M.	
J.,	and	Tresco,	P.	A.	(2004).	Chronic	
response	of	adult	rat	brain	tissue	
to	implants	anchored	to	the	skull.	
Biomaterials 25,	2229–2237.
Kohler,	K.,	Hartmann,	J.	A.,	Werts,	D.,	and	
Zrenner,	E.	(2001).	Histological		 studies	Frontiers in Neuroengineering  www.frontiersin.org  May 2010  | Volume 3  | Article 8  |  6
Marin and Fernández  Biocompatibility of implantable microelectrodes
Citation: Marin C and Fernández E (2010) 
Biocompatibility of intracortical microe-
lectrodes: current status and future pros-
pects. Front. Neuroeng. 3:8. doi: 10.3389/
fneng.2010.00008
Copyright © 2010 Marin and Fernández. 
This is an open-access article subject to 
an exclusive license agreement between 
the authors and the Frontiers Research 
Foundation, which permits unrestricted 
use, distribution, and reproduction in any 
medium, provided the original authors and 
source are credited.
to	uncoated	neural	probes.	Brain Res. 
1148,	15–27.
Conflict of Interest Statement:	 The	
authors	declare	that	the	research	was	con-
ducted	in	the	absence	of	any	commercial	or	
financial	relationships	that	could	be	con-
strued	as	a	potential	conflict	of	interest.
Received: 29 November 2009; paper pend-
ing published: 26 February 2010; accepted: 
05 May 2010; published online: 28 May 
2010.
	 prostheses.	IEEE Eng. Med. Biol. Mag. 
24,	22–29.
Woodford,	B.	J.,	Carter,	R.	R.,	McCreery,	
D.,	Bullara,	L.	A.,	and	Agnew,	W.	F.	
(1996).	Histopathologic	and	physio-
logic	effects	of	chronic	implantation	of	
microelectrodes	in	sacral	spinal	cord	
of	the	cat.	J. Neuropathol. Exp. Neurol. 
55,	982–991.
Zhong,	Y.,	and	Bellamkonda,	R.	V.	(2007).	
Dexamethasone-coated	neural	probes	
elicit	 attenuated	 inflammatory	
response	and	neuronal	loss	compared	
	 long-term	implantation	of		 electrically	
inactive	epiretinal	microelectrode	
arrays	in	rabbits.	Retina (Philadelphia, 
Pa.) 19,	546–552.
Ward,	M.	P.,	Rajdev,	P.,	Ellison,	C.,	and	Irazoqui,	
P.	P.	(2009).	Toward	a	comparison	of	
microelectrodes	for	acute	and	chronic	
recordings.	Brain Res. 1282,	183–200.
Williams,	D.	F.	(2008).	On	the	mechanisms	
of	biocompatibility.	Biomaterials 29,	
2941–2953.
Wise,	K.	D.	(2005).	Silicon	microsys-
tems	for	neuroscience	and	neural	